logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Anxiety Disorders

    FiltersReset Filters
    25 results

    • ativan

      (lorazepam)
      Bausch Health US LLC
      Usage: Ativan (lorazepam) is indicated for managing anxiety disorders and providing short-term relief from anxiety symptoms, including those related to depressive symptoms. Its long-term efficacy beyond four months has not been established, and periodic reassessment by a physician is recommended.

    • buspirone hcl

      (buspirone hydrochloride)
      Advagen Pharma Ltd
      Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders, particularly Generalized Anxiety Disorder (GAD), and for short-term relief of anxiety symptoms. The drug has shown efficacy even in patients with coexisting depressive symptoms. Long-term effectiveness beyond 3-4 weeks remains unestablished, requiring periodic reassessment by physicians.

    • buspirone hydrochloride

      (Buspirone Hydrochloride)
      Strides Pharma Science Limited
      Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders, particularly Generalized Anxiety Disorder (GAD), and providing short-term relief from anxiety symptoms. It may also alleviate anxiety associated with coexisting depressive symptoms. Long-term efficacy beyond 3-4 weeks remains unproven, necessitating periodic physician reassessment.

    • buspirone hydrochloride

      (Buspirone hydrochloride)
      EPIC PHARMA, LLC
      Usage: Buspirone hydrochloride is indicated for managing anxiety disorders and providing short-term relief from anxiety symptoms. It is particularly effective for patients with Generalized Anxiety Disorder (GAD), including those with coexisting depressive symptoms. Long-term efficacy has not been established, and periodic reassessment is recommended.

    • buspirone hydrochloride

      (buspirone hydrochloride)
      Mylan Pharmaceuticals Inc.
      Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders, particularly Generalized Anxiety Disorder (GAD), and for short-term relief of anxiety symptoms. It can also relieve anxiety in patients with coexisting depressive symptoms. Long-term efficacy beyond 3-4 weeks is not established, although short-term use is supported by studies.

    • buspirone hydrochloride

      (Buspirone Hydrochloride)
      EPIC PHARMA, LLC
      Usage: Buspirone hydrochloride capsules are indicated for managing anxiety disorders and providing short-term relief from anxiety symptoms. It is effective in patients with Generalized Anxiety Disorder (GAD), including those with mild coexisting depressive symptoms, but long-term efficacy beyond 3 to 4 weeks has not been established.

    • buspirone hydrochloride

      (BUSPIRONE HYDROCHLORIDE)
      Aurobindo Pharma Limited
      Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders and providing short-term relief of anxiety symptoms, particularly for patients with Generalized Anxiety Disorder (GAD) who may also experience depressive symptoms. Long-term efficacy beyond a few weeks remains unproven, necessitating periodic reassessment by healthcare providers.

    • chlordiazepoxide and amitriptyline hydrochloride

      (Chlordiazepoxide and Amitriptyline Hydrochloride)
      Micro Labs Limited
      Usage: Chlordiazepoxide and amitriptyline hydrochloride tablets are indicated for treating moderate to severe depression linked with anxiety. They can provide a quicker therapeutic response and minimize treatment failures compared to using each drug alone. Initial symptom relief may occur within the first week of treatment.

    • chlordiazepoxide hydrochloride

      (Chlordiazepoxide Hydrochloride)
      Chartwell RX, LLC
      Usage: Chlordiazepoxide Hydrochloride Capsules are indicated for managing anxiety disorders, short-term relief of anxiety symptoms, treatment of alcohol withdrawal symptoms, and preoperative anxiety. Long-term use beyond four months lacks assessment; physicians should periodically evaluate its necessity for each patient.

    • diazepam

      (Diazepam Oral Solution (Concentrate))
      Chartwell RX, LLC
      Usage: Diazepam is indicated for managing anxiety disorders, short-term anxiety relief, and symptomatic relief in acute alcohol withdrawal. It also aids in alleviating skeletal muscle spasms, spasticity from upper motor neuron disorders, and convulsive disorders as an adjunct therapy. Long-term efficacy has not been established.